Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Social Functioning of LAI Risperidone vs Oral Risperidone in Schizophrenia
NCT00992407Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Janssen Pharmaceutical. Started Dec 2007; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00992407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992407.